Ong SE, Li X, Schenone M, Schreiber SL, Carr SA. Identifying cellular targets of small-molecule probes and drugs with biochemical enrichment and SILAC. Methods Mol Biol. 2012;803:129-40. doi:10.1007/978-1-61779-364-6_9
Strausberg RL, Schreiber SL. From knowing to controlling: a path from genomics to drugs using small molecule probes. Science. 2003;300(5617):294-5. doi:10.1126/science.1083395
Klekota J, Brauner E, Roth FP, Schreiber SL. Using high-throughput screening data to discriminate compounds with single-target effects from those with side effects. J Chem Inf Model. 2006;46(4):1549-62. doi:10.1021/ci050495h
Koehler AN. A complex task? Direct modulation of transcription factors with small molecules. Curr Opin Chem Biol. 2010;14(3):331-40. doi:10.1016/j.cbpa.2010.03.022
Schreiber SL. Target-oriented and diversity-oriented organic synthesis in drug discovery. Science. 2000;287(5460):1964-9.
Wagner BK, Kitami T, Gilbert TJ, et al. Large-scale chemical dissection of mitochondrial function. Nat Biotechnol. 2008;26(3):343-51. doi:10.1038/nbt1387
Wagner BK. Screening: Low-fat worms on drugs. Nat Chem Biol. 2011;7(4):194-5. doi:10.1038/nchembio.540
Tibbitt MW, Dahlman JE, Langer R. Emerging Frontiers in Drug Delivery. J Am Chem Soc. 2016;138(3):704-17. doi:10.1021/jacs.5b09974
Hyman SE. Revolution stalled. Sci Transl Med. 2012;4(155):155cm11. doi:10.1126/scitranslmed.3003142
Seiler KP, Kuehn H, Happ MP, Decaprio D, Clemons PA. Using ChemBank to probe chemical biology. Curr Protoc Bioinformatics. 2008;Chapter 14:Unit 14.5. doi:10.1002/0471250953.bi1405s22